Search results
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives Consensus Rating of “Buy” from Analysts
ETF DAILY NEWS· 1 day agoShares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) have earned a consensus recommendation of “Buy” from the nine ratings firms that are presently covering the firm, MarketBeat ...
Taysha Gene Therapies Inc [TSHA] Insider Activity: An Update for Investors – Knox Daily
Knox Daily· 7 days agoB now holds 16,466,667 shares, worth roughly $56.48 million. Piper Sandler initiated its Taysha Gene Therapies Inc [TSHA] rating to an Overweight in a research note published ...
Analysts Set TransMedics Group, Inc. (NASDAQ:TMDX) Target Price at $128.25
ETF DAILY NEWS· 6 hours agoOne analyst has rated the stock with a hold rating and nine have assigned a buy rating to the company. The average 12-month price objective among brokers that have updated ...
What's the Difference Between Ozempic and Metformin, and Which One Is Right for You?
Parade via Yahoo News· 4 days agoCost Price is a significant differentiating factor between the two. "Metformin is generally...
Merck shares maintain Outperform rating amid ongoing clinical trials By Investing.com
Investing.com· 6 days agoOn Tuesday, BMO Capital maintained its Outperform rating on Merck & Co. Inc. (NYSE:MRK), with a...
Analysts Set Expectations for Integer Holdings Co.’s Q3 2025 Earnings (NYSE:ITGR)
ETF DAILY NEWS· 7 hours agoInteger Holdings Co. (NYSE:ITGR – Free Report) – Analysts at Zacks Research lowered their Q3 2025 earnings per share estimates for Integer in a note issued to investors on ...
Myka Stauffer Wore $6K Cartier Bracelet in Vlog About Cutting Adopted Son Huxley's Speech Therapy...
People via Yahoo News· 3 days agoAs she discussed her plans, she wore an 18-karat gold Cartier ...
KalVista presents HAE patient challenges at EAACI Congress By Investing.com
Investing.com· 7 days agoThe findings, derived from various patient surveys, highlighted the difficulties in managing...
Biohaven Ltd. (NYSE:BHVN) Given Average Recommendation of “Buy” by Brokerages
ETF DAILY NEWS· 8 hours ago(NYSE:BHVN – Get Free Report) have been assigned an average rating of “Buy” from the eight ratings firms that are covering the company, Marketbeat reports. TD Cowen raised their target
India Has Low-Cost CAR T-Cell Therapy: Can US Follow Suit?
Medscape· 4 days agoDr Maurie Markman discusses a news report on decreasing the cost of CAR-T therapy and the potential...